Changchun BCHT Biotechnology Co.

About us

Changchun BCHT Biotechnology Co. (hereinafter referred to as “BCHT” or “the company”) is an innovative biopharmaceutical enterprise committed to the prevention and control of infectious diseases. Since its establishment in 2004, BCHT has been engaged in research and development, manufacturing and distribution of vaccines for human use. Through years of development, BCHT has gradually established a complete operation system around core products and implemented quality management in the whole life cycle of products, including raw material procurement, project R&D, production management, product circulation, quality control and quality assurance. All links have strict management measures and internal control systems. BCHT now has its own vaccine manufacturing base which cover 225,700 square meters in total. Relying on its core technology R&D and industrialization capabilities, BCHT has formed a stable business model, high market recognition and respectable social image. In June 2021, the company made its initial public offering and was successfully listed on the Science and Technology Innovation Board.